-
Since around FY2018, the recording of impairment losses has increased. Was some mistake made in a fundamental area? Could you explain the causes once again, from the perspective of business structure?
-
An impairment loss was recorded in these FY2019 interim results, so can you avoid this kind of sudden negative surprise through communication, such as revealing all possible future risks in a single stroke?
-
My greatest concern is what the Company will do with animal nutrition in the future. My impression is that the in-house production ratio for lysine high at 80%. We understand that production capacity has been reduced by 50%, but there has been no explanation for this. From the point of view of a fund manager who is not always watching the Company, a contradiction remains in that what the Company says is different from the results.
-
Although there are some positive areas that are growing, such as the AminoScience business, I have a feeling that negative factors have continued slipping in during the era of President Nishii, which is a waste. If the response to the yet-remaining animal nutrition commodities had been several years earlier, I think that at the present stage it could have been switched to the next area of growth. While the presence of legacy assets is fine, the fact that the current 80% ratio of in-house production of lysine seems to show a loss of speediness suggests that a mistake was made in the response several years ago.
-
Many leading companies in Japan are changing their business structure. Isn’t the difference between those companies and Ajinomoto Co. one of affinity with the main business? For example, are there any areas that can be diverted a bit more to deliciousness, nutrition, and health using new technologies in Healthcare? Perhaps one of the reasons why the Company has not done this is a barrier between pharmaceuticals and foods.
-
I believe that the Company has worked with other companies (Toray Industries, Inc. and Bridgestone Corporation) that are active in technology open innovation, but I have not heard much in the way of results. I feel that there are some challenges unique to the Company when restructuring a business into a new business, but is that the case?
-
In recent years, local competitors have come on aggressively, such as in flavor seasonings in Vietnam and canned coffee in Thailand. The Company was eventually able to make a good recovery, but why was it attacked in the first place?
-
The Company’s overseas business is experiencing unexpected events with considerable frequency. I’m unable to shake the impression that the Company’s responses may be too late. At the interim results briefing, there was a statement to the effect that information from Vietnam should have reached management a bit faster. I think there are still issues with the speed of information transmission. What is necessary to reduce volatility and create a system that lets the Company earn profits stably overseas as a food company?
-
When a question came up at the interim results briefing about how the Company will respond to local competitors beginning to catch up, you were told that the Company would create a Savories Dept. globally and would unify information between Japan and overseas. Could you explain how this will enable the Company to address competition?
-
The rise of local players in emerging countries is likely to continue. As a result, while there had been a shared understanding that a certain margin would be maintained, there is now an unexpected degree of discounting. Amid this, what sort of fight do you think the Company will put up?
-
I think the Company’s strength in its international seasonings business is localization. Going forward, it looks like head office is taking the lead in terms of product development and marketing, but won’t there be some areas where staff in Japan are not aware of changes happening locally?
-
Regarding the international seasonings business, it is my understanding that you personally think that implementing what the Company has done in Japan would not be suitable in other areas. Changes in the competitive environment have resulted in successive downward revisions of results forecasts, so isn’t there a risk that unless significant action is taken, this will continue to happen?
-
In the international seasonings business, what competitive advantages does the Company have, such as strength in in-house sales force training for TT?
-
With consumer demand becoming more sophisticated and the ratio of MT rising among sales channels as well, I think that the Company won’t be able to capture demand or margins if it doesn’t make its products more sophisticated. Do you think that the product lineup is sufficient for current conditions? What are your thoughts on the lineup, including processed foods and frozen foods?
-
Until now, the Company was strong because it had a distribution structure rooted in TT. With e-commerce expanding overseas as well, can the Company continue to function stably under its current structure?
-
I fully understand that the Company’s amino acid research and development capabilities are excellent, but there are areas that are difficult to understand from a perspective in the food industry. In the next MTP, the Company is trying to create a new Ajinomoto Co. How will you practice governance and monetize when pursuing innovation? My personal opinion is that Ajinomoto Co. both is and is not a food company. For example, very mature food companies in Europe are committed to FMCG. The global picture seems to be that so-called upstream innovation is outsourced. However, Japanese companies, including Ajinomoto Co., are integrated. As we consider the global competition of the future, can the Company really win in speed and scale? How do you hope to see Ajinomoto Co. viewed as a company in the future?
-
The appeal of AJI-NO-MOTO® for reducing salt has great potential and is interesting. When will you start tackling that full-scale? Also, in doing so, the Company’s brands vary among Southeast Asian countries. Is there a risk that efforts can’t be implemented horizontally throughout Southeast Asia? I think there may be a need to rethink this situation. What do you think?
-
I understand the reduced salt strategy, but won’t it be meaningless if causes price competition? I feel it will be difficult if the products don’t have some differentiating factor that will let the Company’s brand benefit most. If the result is not one that benefits the Company most, I feel this will end up leading to a defeat. How do you intend to address this?
-
Please explain why you have not been showcasing the salt reducing effects of umami seasonings up to now and why you are able to do so going forward.
-
Do you have any ideas about launching a new seasoning focused on salt reduction?
-
Aren’t there also difficulties marketing to MT and affluent people which are not just limited to salt reduction? What do you intend to do regarding menu-specific seasonings and the like?
-
Regarding salt reduction, what kinds of messages are you communicating globally and what kinds of initiatives do you intend to implement?
-
In Japan, people have the image that Japanese food contains a lot of salt, but are there a lot of consumers who are concerned about salt reduction overseas?
-
I’d like to ask about pricing strategy for reduced salt products. As they offer added value, will you sell them at a higher price? Or do you see them as in demand and plan to realize results through volume rather than price?
-
I think distribution in Japan is changing significantly at the moment. CVS operating hours are changing and there is talk of mass store closures. What is your view on this in regard to the frozen foods and coffee businesses in Japan?
-
Previously you were talking about concentrating on flagship products so that you will be able to compete evenly with global competitors in the near future. For example, I think that fried rice products and Gyoza are definitely your strong frozen food products in Japan, but by further advancing the asset-light model, I think there is also a risk of starting a downward spiral. What significant leaps forward do you plan to have achieved by about 10 years into the future?
-
I think that switching to a consumer perspective will be very important going forward. Imagine that rather than a focus on health, consumers decide that they want flavors containing little or no MSG. Are you already able to respond by changing product development in line with this, or will you do this going forward?
-
Up to now, one of the fundamentals of the Company has been to keep investment within the cash flow of affiliates. Going forward, are we to understand that investment in reduced salt products even in countries without sufficient cash flow will be an effect of global business unification that includes organizational reform?
-
The Company is making great efforts on cost streamlining and margin control in Japan and Southeast Asia, but I would like to see more top-line momentum. I think that small-mass markets, digital, health and nutrition, and so on will be added as new fields, but won’t this be difficult if momentum in existing fields does not also increase? Thinking ahead to the next five years, what should we expect?
-
There have been four broad business segments up to now, but I believe that the Company plans to change its business structure and set six core businesses in the next MTP. I think that the further segmentation will make the business structure more complicated. How does management view the situation?
-
To what extent will the head office exert a grip in the future? Please describe specifically the areas where authority had been local but is coming to be led by the head office.
-
You mentioned that the advanced nations in digital are the United States and China. I think these differ a bit from the regions where the Company engages in the seasonings business, but are these not necessarily linked?
-
Among the Company’s core businesses from FY2020 onward, I think that the strategies for digital and health address perhaps half of these. Do you intend to make investments in the areas not addressed and accelerate growth?
-
Over the three years of the next MTP, operating cash inflow is 350 billion yen, about the same under the current MTP. Is this level acceptable? While the Company says it is working to streamline cash balance, I think it has expectations for the stock market. How much upside are you aiming for with 350 billion yen set as the minimum? Also, we were told that non-core businesses are still unclear, but will this be resolved in the MTP announcement in February? Or are you saying that this is a sensitive topic, and asking the stock market to endure and believe in the Company’s strategy? In that case, though, there are expectations that cash should be improved. What is your thinking on this?
-
Regarding operating cash flow, you mentioned that you would like to increase cash inflow over the three years of the next MTP from 350 billion yen to nearly 400 billion yen. However, amid a deficit in the animal nutrition business and a sense that the base is falling, there is a gap with respect to that 400 billion yen. I don’t think that a reduction in costs from digital marketing will be at the level of tens of billions of yen. What sort of path do you have in mind? Please tell me, even qualitatively, whether that can really be done.
-
Regarding the impact of the shift to an asset-light model, I think this has yet to be fully communicated to the stock market. Following the closing of the first half of FY2019, what do you think is being communicated the least?
-
Regarding the problem of how to convince implementation teams in the field about asset reduction, how do you plan to increase motivation in the field?Also, I understood that the Company will approach the newly affluent class as a strategy for the future, but looking at international seasonings markets in particular over the past three years, the uncharacteristic beating taken by the Company has led to disappointment in the stock market. How can the Company create mechanisms to prevent such defeats in the future?
-
It seems to me that asset-light management will be an opportunity to change gears. The Company has carried out structural reinforcement throughout its long history, but there were surely good as well as points calling for reflection. What sort of change of gears do you think is important now to secure the growth of both the foods and AminoScience businesses?
-
The Company operates a global business, so I think you face many hidden risks. During the FY2019 interim results period, there were issues in Africa and Vietnam. Going forward, how will you ensure that management receives information from the business frontlines quickly so that you can manage risk? What have you changed in light of the problems faced in this period and what has not changed?
-
Will the Company continue conducting strict due diligence while engaging in M&A, as before? Or will it perform management while strictly controlling the current situation? What is your thinking on this?
-
How much say do you have in the governance of equity-method affiliates in which the Company holds a minority stake? Do you plan to participate in overseas M&A as a minority partner going forward? Or are you focusing on making acquisitions as the majority partner in the future?
-
The Company is aiming to become a global top 10 class food company, but will achieving a business profit margin of 13% be enough to do this?
-
I would like to ask about the progress and assessment of work style innovation initiatives. Total actual working hours are being greatly reduced and average salaries are rising, meaning that worker satisfaction is improving. However, from a productivity perspective, my impression is that shorter working hours are being realized before DX. What are your thoughts on this?
-
The Company has made the decision to cut staff by 100 people. Why 100? Also, what is the significance of staff reductions? It may mean a reduction in fixed costs, but I wonder whether it also has a purpose of, for example, raising motivation and tension in remaining employees. I would like to hear about the sense of scale and the purpose, and whether the cuts will continue.
-
Regarding the Special Second Career Program for Managers, how is motivation among employees who are under 50 years old? Won’t they feel uneasy that they will eventually qualify for the program?
-
Regarding the Special Second Career Program for Managers, what kinds of changes are you expecting in relation to people eligible for the program who chose not to leave the company? Although this will create a little leeway in terms of PL from 2020 onwards, what kinds of areas are you planning to reinvest in?
-
In December, you had an interview in Nikkei Business in which you said that the Company could grow by getting the right people in the right positions, and that from FY2016 the Company was advancing a process of establishing full job grades for managers positions and establishing a framework for freely recruiting young personnel as necessary. In regard to the hard aspects of this, I think you are removing the culture of promotion by seniority and advancing the recruitment of external personnel, but how are you handling the soft aspects?
-
Are you going to change assessment and compensation systems for younger employees?
-
Although markets decide the stock price of a company, the awareness and intentions of top management regarding stock price is important. Do you think the temporary rise to 3,000 yen was too high? Or on the other hand, do you think the current price level of about 1,800 yen undervalues the Company’s vision?